Accumulated evidence demonstrates P16INK4a gene promoter hypermethylation is involved in non-small cell lung carcinoma (NSCLC), indicating it may be a potential biomarker for this disease. The gene discussed is CDKN2A; the disease is non-small cell lung carcinoma.